mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.8 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.8 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |